Back to results
US 6,730,487 B2Granted
Surface plasmon resonance biosensor for measurement of anti-glycolipid antibody levels in neuropathy
AssigneeThe Trustees of Columbia University in the City of New York
InventorsNorman Latov, Armin Alaedini
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of detecting human antibodies in a sera solution. The invention also provides a method of quantitating anti-glycolipid antibody levels in solutions. The invention provides a method of diagnosing disease states, including neurological diseases, by quantitating a subject's antibody levels.
Claims12
A method of detecting antibodies in a blood or blood derivative solution comprising:
- a) contacting the blood or blood derivative solution with a ganglioside-coated surface of a sensor chip under conditions that permit the antibodies to bind to the ganglioside coating;
- b) detecting the change in surface plasmon resonance signal of the sensor chip resulting from the antibodies binding to the ganglioside coating.
A method of determining whether a subject is suffering from a neurological disease comprising:
- a) contacting the solution with a sensor chip comprising a ganglioside coated surface under conditions that permit anti-ganglioside antibodies to bind to the ganglioside coating and the sensor chip to emit a surface plasmon resonance signal;
- and
- b) detecting a change in the surface plasmon resonance signal emitted by the sensor chip so as to thereby detect the binding of the antibodies to the ganglioside coating,
- wherein detection of the change in surface plasmon resonance signal indicates the subject is suffering from the neurological disease.
1 more element
Dependencies are inferred from the claim text.